Introduction
Bladder cancer (BC) is the second most frequent malignancy of the urinary tract. BC can be classified as either a nonmuscle-invasive bladder cancer (NMIBC) or a muscle-invasive bladder cancer (MIBC). NMIBC (Ta, carcinoma in situ, and T1) that does not penetrate the basement membrane is rarely associated with patient death. 1 However, MIBC ($T2) is potentially life-threatening metastasis and has a different biology than NMIBC. Despite radical cystectomy and systemic therapy, including immunotherapy, chemotherapy, and radiotherapy, at least 50% of patients with MIBC die from metastases within 2 years of diagnosis. 2, 3 Therefore, exploring the potential mechanisms of BC migration and invasion is urgently needed.
MicroRNAs (miRNAs) are a class of small noncoding (~18-22 nucleotides) RNAs that negatively regulate the expression of target genes by binding to the 3′-untranslated region (3′-UTR). 4 Growing evidence reveals that the disordered expression of miRNA is related to human cancer initiation and progression, including that of miR-21 in prostate cancer, miR-145 in lung cancer, and miR-140 in breast cancer. [5] [6] [7] In the recent years, the aberrant regulation of miRNAs in BC has been suggested to contribute to bladder tumorigenesis. 8 Therefore, the identification of miRNAs in BC is critical. 
Materials and methods clinical specimens and cell lines
A total of 22 paired BC tissues and adjacent nontumor tissues were obtained from patients undergoing radical cystectomy at the First Affiliated Hospital of Nanjing Medical University. A total of 14 paired tissue samples were immediately frozen in liquid nitrogen, and eight paired tissue samples were fixed in formalin. All patients provided their signed informed consent, and this study was approved by the Research Ethics Committee of the First Affiliated Hospital of Nanjing Medical University. The tumor stage was determined according to the 2004 World Health Organization classification.
The human BC cell lines T24 and EJ were obtained from the Type Culture Collection of the Chinese Academy of Sciences (Shanghai, People's Republic of China) and were cultured in Roswell Park Memorial Institute 1640 medium (Thermo Fisher Scientific, Waltham, MA, USA) with 10% fetal bovine serum (Thermo Fisher Scientific), 100 IU/mL penicillin, and 100 µg/mL streptomycin. 293T cell was cultured in Dulbecco's Modified Eagle's Medium with 10% fetal bovine serum. All cells were maintained in a humidified incubator at 37°C with 5% CO 2 .
rna isolation and quantitative reverse transcription polymerase chain reaction Total RNA was extracted from tissue samples and cell lines using miRNeasy Mini Kit (Qiagen NV, Venlo, the Netherlands). RNA was used to synthesize complementary DNA using Mir-X miRNA First-Strand Synthesis Kit (Clontech Laboratories, Inc., USA) for miRNA quantity and PrimeScript™ RT Master Mix (Takara Bio Inc., Japan) for messenger RNA (mRNA) quantity. The levels of miRNA and mRNA were determined through quantitative reverse transcription polymerase chain reaction (qRT-PCR) using SYBR Green Master Mix (Takara Bio Inc., Japan). The primers for Takara Bio Inc., Japan were forward 5′-CCT CAG TGA GCA CAG TTC AGA-3′ and reverse 5′-GCA GCA CAC ACA CTG CTG TA-3′ and for β-actin were forward 5′-AGC GAG CAT CCC CCA AAG TT-3′ and reverse 5′-GGG CAC GAA GGC TCA TCA TT-3′ (Sangon Biotech, Shanghai, People's Republic of China). U6 and β-actin were used as internal controls for miRNA and mRNA quantification. All the reactions were performed in triplicate.
Oligonucleotides transfection
MiR-200c mimics, anti-miR-200c, small interfering RNA of RECK (siRECK), and their corresponding negative controls (miR-NC, anti-miR-NC, and siNC) were purchased from GenePharma (Shanghai, People's Republic of China). T24 and EJ cells were transfected with oligonucleotides using Lipofectamine 2000 reagent (Thermo Fisher Scientific, Waltham, MA, USA) according to the manufacturer's instructions.
Wound healing assay
When the cells reached 95% confluence in six-well plates after transfection, a 200 µL pipette tip was used to draw a wound with the same width. After washing and removing cell debris, the cells were cultured using a serum-free medium under standard conditions. The wound was observed under a microscope (Olympus Corporation, Tokyo, Japan) at 40× magnification at two preselected time points (0 and 24 hours). The widths of the wounds were counted.
Migration and invasion assays
Cell migration and invasion were determined using a transwell chamber (8 µm pore size) with and without BD Matrigel (BD Biosciences, San Jose, CA, USA). The upper side of the membrane was coated with Matrigel for the invasion assay. After 24 hours of transfection, a total of 2×10 4 cells in 200 µL serum-free medium were plated to the upper chambers and 600 µL medium containing 10% serum was used as a chemoattractant in the lower chambers. After 48 hours, the cells on the upper side of the membrane were removed using cotton swabs, and the invaded cells on the lower side of the membrane were fixed, stained, and counted using an inverted microscope at 100× magnification.
Western blot analysis
The cells were lysed after 48 hours of transfection. Their protein was extracted using radioimmunoprecipitation assay buffer and was quantified using a bicinchonininc acid (BCA) Protein Assay Kit (Beyotime, Shanghai, People's Republic of China). Equal amounts of proteins were separated through 10% sodium dodecyl sulfate polyacrylamide gel electrophoresis and were transferred to polyvinylidene difluoride membranes. The membranes were blocked with 5% nonfat milk and were incubated with primary antibodies against RECK (1:1,000; Cell Signaling Technology, Inc., USA), matrix metalloproteinase-2 (MMP-2; 1:1,000; Cell Signaling Technology), and glyceraldehyde 3-phosphate dehydrogenase (Cell Signaling Technology) overnight at 4°C. After washing with Tris-buffered saline containing Tween 20, the membranes were incubated with secondary antirabbit or antimouse antibodies for 1 hour at room temperature and were subsequently detected using a chemiluminescence system (Bio-Rad Laboratories Inc., Hercules, CA).
Bioinformatic and luciferase reporter assay
Mirorna.org, miRBase, and TargetScan were used to predict the potential targets of miR-200c. 293T cells were cotransfected with miR-200c mimics or miR-mimic controls and with wild-type or mutant-type plasmid containing pEZX/RECK-1-3′-UTR or pEZX/RECK-1-3′-UTR, respectively, together with firefly and Renilla luciferase (GeneCopoeia, Rockville, MD) using Lipofectamine 2000. The luciferase activity was determined by using the Luc-Pair miR Luciferase Assay (GeneCopoeia) after 48 hours of cotransfection according to the manufacturer's instructions.
immunohistochemical staining
Formalin-fixed tissue samples were embedded in paraffin and cut into 4 µm sections. Immunohistochemistry staining was performed as previously described. 9 The RECK expression was defined as low and high based on the RECK staining intensity of the cells.
statistical analyses
The results were expressed as mean ± standard deviation and were analyzed using SPSS 16.0 (SPSS Inc., Chicago, IL). All statistical analyses were performed using the SPSS 16.0 software. Data were analyzed using a two-tailed Student's t-test or one-way analysis of variance. P,0.05 was considered statistically significant.
Results

Mir-200c is upregulated in Bc clinical specimens
To decreased the mobility of BC cells (Figure 2A and B) . Similarly, the migration and invasion assays showed that antimiR-200c significantly inhibited the migratory and invasive abilities of BC cells but not those of the control (Figure 2C-E) . These results suggested that miR-200c significantly contributed to the migration and invasion of BC cells.
Mir-200c directly regulates recK
We found that RECK could be a potential target of miR-200c, and this finding was confirmed in our study through bioinformatics analysis ( Figure 3A) . Based on the publicly available algorithms, the 3′-UTR of the RECK gene contains two complementary sites for miR-200c. We then performed 
silencing of recK promotes migration and invasion of Bc cells
To further determine miR-200c-regulated cell migration and invasion in BC cells by modulating RECK, we cotransfected EJ and T24 cell lines with siRECK and anti-miR-200c. The RECK protein levels were determined through Western blot assay ( Figure 4A and B) . The downregulation of RECK treated with siRECK was evidently counteracted by anti-miR200c. Moreover, cell migration and invasion were confirmed by the wound healing and transwell assays. As expected, a reduction in RECK protein levels increased the migration and invasion of EJ and T24 cell lines ( Figure 4C-G) . Conversely, the increased RECK expression suppressed the migratory and invasive ability of EJ and T24 cell lines ( Figure 4C-G) . These results showed that the migratory and invasive abilities of BC cells decreased as RECK expression increased and suggested that miR-200c promoted the migration and invasion of BC cells through the miR-200c/RECK signaling axis.
recK is downregulated in Bc clinical specimens
The qRT-PCR analysis demonstrated that the RECK mRNA level was markedly reduced in the BC tissues but not in the normal tissues ( Figure 5A ). Immunohistochemistry assays on bladder tissues showed low RECK protein expression through the weak staining in the tumor tissues compared with the normal tissues ( Figure 5B ). In addition, RECK was detected in the cytoplasm and plasma membrane of normal BC cells, consistent with the results of other studies. 
Discussion
Metastasis is responsible for as much as 90% of cancerrelated mortality, but it remains the most poorly understood component of cancer pathogenesis. 12 The migration and invasion of cancer cells may be the key steps in this complex multistep process through which cancer cells disseminate and spread from a primary tumor to distant sites, forming secondary tumors in other organs and tissues. 13, 14 Increasing current evidence suggests that aberrant miRNA expression contributes to invasion and metastasis. 15, 16 miRNAs have already been known to be involved in the initiation, development, and metastasis of BC, and several of them can function as oncogenes or as tumor suppressors by regulating the expression of their target genes. 17 The miR-200 family is involved in the epithelial-to-mesenchymal transition, tumor cell invasion and metastasis, and self-renewal of cancer stem cells. 18 miR-200c, as the prevailing member of the miRNA-200 family, has been demonstrated to be important in modulating tumor biology. Currently, miR-200c has been reported to be upregulated in melanoma and ovarian cancer 19, 20 and downregulated in renal cell carcinoma and gastric cancer, 21, 22 functioning as an oncogene and a tumor suppressor, respectively. Consequently, the dual roles of miR-200c may occur in different types of cancer in a tissuespecific manner. Nevertheless, miR-200c has been reported to be upregulated in BC, 23, 24 whereas others have reported it to be downregulated. 25 These contradictory findings may be in part due to the different models applied in these studies. Therefore, the roles of miR-200c in BC are also ambiguous, and its definite function needs to be further investigated.
To affirm the role of miR-200c in BC in more detail, we first ascertained the expression of miR-200c in BC specimens. We found that miR-200c expression was upregulated in BC but not in adjacent nontumor tissues. Moreover, increased miR-200c expression was observed in MIBC but not in NMIBC. Subsequently, we selected the two invasive BC cell lines T24 and EJ for the miR-200c loss-of-function assays. We found that the knockdown of miR-200c in T24 and EJ cell lines resulted in decreased migratory and invasive abilities, thus indicating the migratory and invasive promoter role of miR-200c in BC.
Identifying the downstream target genes of miR-200c can contribute to the understanding of its potential molecular mechanisms. We used bioinformatics analysis to search for potential targets of miR-200c. RECK, a gene previously implicated in metastasis and invasiveness, 10, 26 was identified to be the highest possible target of miR-200c. As a membrane-anchored glycoprotein, the RECK protein mainly functions in tissue remodeling and inhibits the activity of MMPs. 27, 28 MMPs proteolytically degrade extracellular matrix proteins, which are critical for tumor metastasis and invasion. Moreover, Wittschieber et al 11 reported that decreased RECK expression is associated with increasing stage and grade of BC and could serve as a molecular marker for the distinction between NMIBC and MIBC. As a member of the MMPs, MMP-2 evidently decreased and RECK significantly increased in the anti-miR-200c group in this study ( Figure 3C ). These results were consistent with those of other research. 27, 29 Therefore, our hypothesis is that miR-200c promotes BC cell migration and invasion by targeting RECK through the inhibition of MMP-2 expression. We demonstrated that miR-200c directly bound the RECK 3′-UTR and that the knockdown of miR-200c increased the RECK protein expression. However, the unchanged RECK mRNA level could have been due to the posttranscriptional regulation (data not shown). Subsequently, the knockdown of RECK with siRNA induced a significant increase in the migration and invasion abilities of BC cells. Thus, we suggested that miR-200c negatively regulated the expression of RECK and affected the biological processes of BC.
Conclusion
In summary, our study revealed that miR-200c is overexpressed and acts as an oncogene in BC. To the best of our knowledge, this is the first study to demonstrate that miR-200c promotes the migration and invasion of BC cells through the downregulation of MMPs by targeting RECK. Consequently, the identification of miR-200c may help us understand the potential molecular mechanisms of BC tumorigenesis and may provide a novel therapeutic strategy for the treatment of BC.
